Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray

Mostrar otras versiones (1)

The current practice for diagnosis of COVID-19, based on SARS-CoV-2 PCR testing of pharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic risk, likely underestimates the true prevalence of infection. Serologic methods can more accurately estimate the disease burden by det...

Descripción completa

Detalles Bibliográficos
Autores principales: de Assis, Rafael R., Jain, Aarti, Nakajima, Rie, Jasinskas, Algis, Felgner, Jiin, Obiero, Joshua M., Adenaiye, Oluwasanmi, Tai, Sheldon, Hong, Filbert, Norris, Philip J., Stone, Mars, Simmons, Graham, Bagri, Anil, Schreiber, Martin, Buser, Andreas, Holbro, Andreas, Battegay, Manuel, Hosimer, Philip, Noesen, Charles, Milton, Donald K., Davies, D. Huw, Contestable, Paul, Corash, Laurence M., Busch, Michael P., Felgner, Philip L., Khan, Saahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217240/
https://www.ncbi.nlm.nih.gov/pubmed/32511302
http://dx.doi.org/10.1101/2020.04.15.043364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217240/
https://www.ncbi.nlm.nih.gov/pubmed/32511302
http://dx.doi.org/10.1101/2020.04.15.043364

Ejemplares similares